Projects
The work I am involved in spans clinical research, healthcare operations, and advocacy for psychedelic medicine.
Axonklinikken
Scandinavia's first ketamine-assisted psychotherapy clinic, with over 5,000 treatments delivered across two locations since 2018.
NorRAD
National network of consultant psychiatrists that designed the ten-hospital trial behind Norway's 2025 decision to publicly fund ketamine treatment.
PsykForsk, Sykehuset Ostfold
Established Scandinavia's first public hospital ketamine unit and oversaw Norway's first MDMA-assisted psychotherapy trial.
University of Oslo Psychedelic Research
Collaborating on psychedelic phenomenology studies and neuroscience research at the University of Oslo.
UNN Ketamine Trial
Randomized controlled trial of ketamine for depression with comorbid alcohol dependence, in collaboration with Dr. Andreas Blomkvist.
Norsk forening for psykedelisk vitenskap
Co-founded Norway's first professional network for psychedelic science, bringing together researchers, clinicians, and policymakers.
Axon Research Foundation
Foundation funding ketamine treatment for veterans, healthcare workers, and trauma survivors, alongside clinical research.
Oslo New University College (ONH)
Research collaboration investigating ketamine-assisted psychotherapy for eating disorders.
Interested in collaborating?
Open to multi-site studies, advisory roles, and academic partnerships.